In addition, immunohistochemical evaluation also indicated a decrease in NLRP3 expression in colon sections of DSS-induced mice, suggesting a potential role for SMS in the treatment of IBD through suppression of NLRP3. The gene discussed is NLRP3; the disease is inflammatory bowel disease.